Literature DB >> 34173117

Reference Module-Based Analysis of Ovarian Cancer Transcriptome Identifies Important Modules and Potential Drugs.

Xuedan Lai1, Peihong Lin1, Jianwen Ye1, Wei Liu2, Shiqiang Lin2, Zhou Lin3.   

Abstract

Ovarian cancer (OVC) is often diagnosed at the advanced stage resulting in a poor overall outcome for the patient. The disease mechanisms, prognosis, and treatment require imperative elucidation. A rank-based module-centric framework was proposed to analyze the key modules related to the development, prognosis, and treatment of OVC. The ovarian cancer cell line microarray dataset GSE43765 from the Gene Expression Omnibus database was used to construct the reference modules by weighted gene correlation network analysis. Twenty-three reference modules were tested for stability and functionally annotated. Furthermore, to demonstrate the utility of reference modules, two more OVC datasets were collected, and their gene expression profiles were projected to the reference modules to generate a module-level expression. An epithelial-mesenchymal transition module was activated in OVC compared to the normal epithelium, and a pluripotency module was activated in ovarian cancer stroma compared to ovarian cancer epithelium. Seven differentially expressed modules were identified in OVC compared to the normal ovarian epithelium, with five up-regulated, and two down-regulated. One module was identified to be predictive of patient overall survival. Four modules were enriched with SNP signals. Based on differentially expressed modules and hub genes, five candidate drugs were screened. The hub genes of those modules merit further investigation. We firstly propose the reference module-based analysis of OVC. The utility of the analysis framework can be extended to transcriptome data of other kinds of diseases.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Differential module expression; Gene co-expression network; Hub gene; Transcriptome; WGCNA

Mesh:

Substances:

Year:  2021        PMID: 34173117     DOI: 10.1007/s10528-021-10101-7

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  54 in total

1.  Genetic network inference: from co-expression clustering to reverse engineering.

Authors:  P D'haeseleer; S Liang; R Somogyi
Journal:  Bioinformatics       Date:  2000-08       Impact factor: 6.937

Review 2.  Network medicine: a network-based approach to human disease.

Authors:  Albert-László Barabási; Natali Gulbahce; Joseph Loscalzo
Journal:  Nat Rev Genet       Date:  2011-01       Impact factor: 53.242

Review 3.  Multiple modes of action of eribulin mesylate: Emerging data and clinical implications.

Authors:  Javier Cortes; Patrick Schöffski; Bruce A Littlefield
Journal:  Cancer Treat Rev       Date:  2018-08-21       Impact factor: 12.111

4.  NCBI GEO: archive for functional genomics data sets--update.

Authors:  Tanya Barrett; Stephen E Wilhite; Pierre Ledoux; Carlos Evangelista; Irene F Kim; Maxim Tomashevsky; Kimberly A Marshall; Katherine H Phillippy; Patti M Sherman; Michelle Holko; Andrey Yefanov; Hyeseung Lee; Naigong Zhang; Cynthia L Robertson; Nadezhda Serova; Sean Davis; Alexandra Soboleva
Journal:  Nucleic Acids Res       Date:  2012-11-27       Impact factor: 16.971

5.  Gene expression profiling reveals epithelial mesenchymal transition (EMT) genes can selectively differentiate eribulin sensitive breast cancer cells.

Authors:  Zoltán Dezső; Judith Oestreicher; Amy Weaver; Stephanie Santiago; Sergei Agoulnik; Jesse Chow; Yoshiya Oda; Yasuhiro Funahashi
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

Review 6.  Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy.

Authors:  Hong-Tao Chen; Hao Liu; Min-Jie Mao; Yuan Tan; Xiang-Qiong Mo; Xiao-Jun Meng; Meng-Ting Cao; Chu-Yu Zhong; Yan Liu; Hong Shan; Guan-Min Jiang
Journal:  Mol Cancer       Date:  2019-05-24       Impact factor: 27.401

7.  Mesenchymal stromal cell-derived extracellular vesicles for regenerative therapy and immune modulation: Progress and challenges toward clinical application.

Authors:  David Allan; Alvin Tieu; Manoj Lalu; Dylan Burger
Journal:  Stem Cells Transl Med       Date:  2019-08-14       Impact factor: 6.940

8.  Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming.

Authors:  Nicolas Christoforou; Malathi Chellappan; Andrew F Adler; Robert D Kirkton; Tianyi Wu; Russell C Addis; Nenad Bursac; Kam W Leong
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

9.  Single-cell Co-expression Subnetwork Analysis.

Authors:  Thomas E Bartlett; Sören Müller; Aaron Diaz
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

10.  The role of GRHL2 and epigenetic remodeling in epithelial-mesenchymal plasticity in ovarian cancer cells.

Authors:  Vin Yee Chung; Tuan Zea Tan; Jieru Ye; Rui-Lan Huang; Hung-Cheng Lai; Dennis Kappei; Heike Wollmann; Ernesto Guccione; Ruby Yun-Ju Huang
Journal:  Commun Biol       Date:  2019-07-24
View more
  2 in total

1.  Gene Network Analysis of Hepatocellular Carcinoma Identifies Modules Associated with Disease Progression, Survival, and Chemo Drug Resistance.

Authors:  Hua Ye; Mengxia Sun; Shiliang Huang; Feng Xu; Jian Wang; Huiwei Liu; Liangshun Zhang; Wenjing Luo; Wenying Guo; Zhe Wu; Jie Zhu; Hong Li
Journal:  Int J Gen Med       Date:  2021-12-04

2.  Characterization and Expression Analyses of Callose Synthase Enzyme (Cals) Family Genes in Maize (Zea mays L.).

Authors:  Qunkai Niu; Peng Zhang; Shuai Su; Bin Jiang; Xiaowei Liu; Chuan Li; Tao Yu; Hongyang Yi; Jin Tang; Moju Cao
Journal:  Biochem Genet       Date:  2021-07-05       Impact factor: 1.890

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.